目录
- Progress and challenges in testicular cancer microRNAs
- Blood and urine biomarkers in prostate cancer:Are we ready for reflex testing in men with an elevated prostate-specific antigen?
- Future perspective of focal therapy for localized prostate cancer
- Biomarkers in renal cell carcinoma:Are we there yet?
- Molecular markers of systemic therapy response in urothelial carcinoma
- The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
- MicroRNA-371a-3p as a blood-based biomarker in testis cancer
- Alternative polyadenylation:An untapped source for prostate cancer biomarkers and therapeutic targets?
- Impact of COVID-19 on endourology surgical practice in Saudi Arabia:A national multicenter study
- A novel spherical-headed fascial dilator is feasible for second-stage ultrasound guided percutaneous nephrolithotomy:A pilot study
- Effect of tamsulosin versus tamsulosin plus tadalafil on renal calculus clearance after shock wave lithotripsy:An open-labelled,randomised,prospective study
- Perioperative anticoagulation and open distal corpora cavernosa shunt in the management of a case of stuttering idiopathic persistent childhood ischaemic priapism
- Metachronous chest wall metastasis from clear cell renal cell carcinoma-A rarity
- Late upper urinary tract urothelial carcinoma following radical cystectomy,presenting as page kidney
- Radical cystoprostatectomy with orthotopic neobladder for a case of treatment emergent neuroendocrine prostate cancer presenting as bladder mass with hematuria-a rare instance of tumor remission after local control